| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Jan 07, 2026 | Option/RSU Exercise | $8.02 | 31,261 | 250,713 | 38,490 | Jan 07, 2026, 07:00 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Jan 07, 2026 | Sale | $170.38 | 31,261 | 5,326,249 | 7,229 | Jan 07, 2026, 07:00 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Jan 05, 2026 | Option/RSU Exercise | $8.02 | 78,703 | 631,198 | 85,932 | Jan 07, 2026, 07:00 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Jan 05, 2026 | Sale | $171.28 | 78,703 | 13,480,250 | 7,229 | Jan 07, 2026, 07:00 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Jan 06, 2026 | Option/RSU Exercise | $8.02 | 29,450 | 236,189 | 36,679 | Jan 07, 2026, 07:00 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Jan 06, 2026 | Sale | $172.33 | 29,450 | 5,075,119 | 7,229 | Jan 07, 2026, 07:00 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Dec 04, 2025 | Sale | $148.18 | 10,558 | 1,564,484 | 7,229 | Dec 04, 2025, 07:39 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Dec 02, 2025 | Option/RSU Exercise | $8.02 | 49,252 | 395,001 | 56,481 | Dec 04, 2025, 07:39 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Dec 02, 2025 | Sale | $144.59 | 49,252 | 7,121,346 | 7,229 | Dec 04, 2025, 07:39 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Dec 03, 2025 | Option/RSU Exercise | $8.02 | 20,163 | 161,707 | 27,392 | Dec 04, 2025, 07:39 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Dec 03, 2025 | Sale | $146.94 | 20,163 | 2,962,751 | 7,229 | Dec 04, 2025, 07:39 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Dec 04, 2025 | Option/RSU Exercise | $8.02 | 10,558 | 84,675 | 17,787 | Dec 04, 2025, 07:39 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Nov 05, 2025 | Sale | $134.49 | 21,775 | 2,928,520 | 7,229 | Nov 05, 2025, 07:01 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Nov 03, 2025 | Option/RSU Exercise | $8.02 | 91,705 | 735,474 | 98,934 | Nov 05, 2025, 07:01 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Nov 03, 2025 | Sale | $132.34 | 91,705 | 12,136,239 | 7,229 | Nov 05, 2025, 07:01 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Nov 04, 2025 | Option/RSU Exercise | $8.02 | 50,459 | 404,681 | 57,688 | Nov 05, 2025, 07:01 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Nov 04, 2025 | Sale | $133.79 | 50,459 | 6,750,909 | 7,229 | Nov 05, 2025, 07:01 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Nov 05, 2025 | Option/RSU Exercise | $8.02 | 21,775 | 174,636 | 29,004 | Nov 05, 2025, 07:01 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Oct 06, 2025 | Sale | $120.17 | 19,220 | 2,309,667 | 7,229 | Oct 08, 2025, 09:08 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Oct 07, 2025 | Option/RSU Exercise | $8.02 | 13,390 | 107,388 | 20,619 | Oct 08, 2025, 09:08 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Oct 07, 2025 | Sale | $118.77 | 13,390 | 1,590,330 | 7,229 | Oct 08, 2025, 09:08 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Oct 08, 2025 | Option/RSU Exercise | $8.02 | 12,774 | 102,447 | 20,003 | Oct 08, 2025, 09:08 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Oct 08, 2025 | Sale | $118.84 | 12,774 | 1,518,062 | 7,229 | Oct 08, 2025, 09:08 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Oct 06, 2025 | Option/RSU Exercise | $8.02 | 19,220 | 154,144 | 26,449 | Oct 08, 2025, 09:08 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Sep 12, 2025 | Sale | $118.96 | 27,907 | 3,319,817 | 7,229 | Sep 16, 2025, 07:36 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Sep 15, 2025 | Option/RSU Exercise | $8.02 | 15,254 | 122,337 | 22,483 | Sep 16, 2025, 07:36 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Sep 15, 2025 | Sale | $117.37 | 15,254 | 1,790,362 | 7,229 | Sep 16, 2025, 07:36 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Sep 16, 2025 | Option/RSU Exercise | $8.02 | 19,719 | 158,146 | 26,948 | Sep 16, 2025, 07:36 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Sep 16, 2025 | Sale | $114.19 | 19,719 | 2,251,713 | 7,229 | Sep 16, 2025, 07:36 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Sep 12, 2025 | Option/RSU Exercise | $8.02 | 27,907 | 223,814 | 35,136 | Sep 16, 2025, 07:36 PM |
| AXSM | | Axsome Therapeutics, Inc. | Herriot Tabuteau | Chief Executive Officer | Nov 24, 2015 | Conversion | $5.94 | 7,229 | 42,940 | 7,229 | Nov 24, 2015, 04:24 PM |